Komori
Other Disclosures4875MediciNova,Inc.Pharmaceuticals

Notice regarding participation in the 38th Annual Conference hosted by ROTH

The company will participate in the 38th ROTH Annual Conference, to be held in the United States from 22 to 24 March 2026, and plans to provide investors with the latest project updates in one-on-one and small-group meetings.

Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Applicable field (uses covered by this announcement)

投資家向けミーティング、当社プロジェクトの最新情報説明

Launch date2026年3月22日~3月24日(米国時間、開催予定)
Relationship between the counterparty and the company
MediciNova,Inc.4875
Relationship with the Company

当社がROTH主催のカンファレンスに参加する関係。資本関係・人的関係はNot disclosed。

CounterpartyROTH

カンファレンスを主催する会社。所在地・代表者・事業内容・資本金・設立年はNot disclosed。

Location (as indicated in this announcement)

The Ritz-Carlton, Dana Point, California(カンファレンス会場)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

ROTH公式Webサイト(https://www.roth.com/conferences)

Announced details
ItemDetails
CounterpartyROTH
Counterparty overviewカンファレンスを主催する会社。所在地・代表者・事業内容・資本金・設立年はNot disclosed。
Relationship with the Company当社がROTH主催のカンファレンスに参加する関係。資本関係・人的関係はNot disclosed。
Launch date2026年3月22日~3月24日(米国時間、開催予定)
Applicable area投資家向けミーティング、当社プロジェクトの最新情報説明
LocationThe Ritz-Carlton, Dana Point, California(カンファレンス会場)
SourceROTH公式Webサイト(https://www.roth.com/conferences)
Items this document does not state (11)
Names of Products / Services CoveredContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

投資家との1対1および小規模グループでのミーティングを実施し、当社のプロジェクトの最新情報等を説明するため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice regarding participation in the 38th Annual Conference hosted by ROTH | MediciNova,Inc. (4875) timely disclosure | Komori